Listed

Boston Scientific Corp: Form 10-Q for the period ended Mar 31, 2022

Filed with the SEC on May 5, 2022 and accepted by EDGAR at May 5, 2022, 16:11 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-01-01 to 2022-03-31$3.03bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-01-01 to 2022-03-31$955.0mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-01-01 to 2022-03-31$2.07bnus-gaap:GrossProfit
Selling, general and administrative3 months2022-01-01 to 2022-03-31$1.06bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-01-01 to 2022-03-31$466.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-01-01 to 2022-03-31$279.0mus-gaap:InterestExpense
Income tax3 months2022-01-01 to 2022-03-31$45.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-01-01 to 2022-03-31$110.0mus-gaap:ProfitLoss
Diluted EPS3 months2022-01-01 to 2022-03-31$0.07us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-01-01 to 2022-03-31$0.07us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-01-01 to 2022-03-311,438,400,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2022-01-01 to 2022-03-31−$58.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-01-01 to 2022-03-31$121.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2022-01-01 to 2022-03-31$14.0mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2022-03-31$325.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-03-31$5.07bnus-gaap:AssetsCurrent
Total assetsAt period end2022-03-31$32.34bnus-gaap:Assets
Current liabilitiesAt period end2022-03-31$4.28bnus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2022-03-31$238.0mus-gaap:DebtCurrent

Source: SEC EDGAR, the filing index for accession 0000885725-22-000013. Last ingested by Listed: Nov 6, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.